Microbiota modulation by a human Paneth cell α-defensin fragment protects against DSS-induced colitis
The gastrointestinal tract hosts a diverse microbial community, named the intestinal microbiota, which plays a vital role in gut health. Host defense peptides (HDPs), such as defensins, help regulate interactions between the host and its microbiota. Dysfunction in HDPs expression has been associated with a greater risk of inflammatory bowel diseases (IBDs), while some HDPs may positively shape the gut environment. Human alpha defensin 5 (HD5) can be cleaved by intestinal enzymes into bioactive fragments such as HD5<sub>1-9</sub>. In this study, we screened various HDPs (LL-37, hBD2, HD5, and HD5<sub>1-9</sub>) for their modulatory effects on healthy human microbiotas <i>in vitro</i> and found distinct, donor-specific effects, with HD5<sub>1-9</sub> showing the strongest functional impact. Testing HD5<sub>1-9</sub> in a mouse colitis model revealed potent and microbiota-dependent protection against DSS-induced inflammation, partly through the beneficial of mucus-microbiota interactions. These findings highlight the potential of HDPs, especially HD5<sub>1-9</sub>, in modulating gut microbiota and treating intestinal inflammation.
Authors
- Fuhua Hao (ORCID: https://orcid.org/0000-0002-0865-5269)
- Benoit Chassaing
- Benjamin A. H. Jensen (ORCID: https://orcid.org/0000-0001-6991-0828)
- Erica Bonazzi
- Andrew D. Patterson (ORCID: https://orcid.org/0000-0003-2073-0070)
- Laurent Peyrin-Biroulet
Institutions
- University of Copenhagen (DK)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Institut Pasteur (FR)
- Université Paris Cité (FR)
- Centre d’Investigation Clinique Innovation Technologique de Nancy (FR)
- Nutrition-Génétique et Exposition aux Risques Environnementaux (FR)
- Université de Lorraine (FR)
Publication Details
- Journal
- iScience
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1016/j.isci.2025.114310
- Primary Topic
- Antimicrobial Peptides and Activities
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fondation de l'Avenir pour la Recherche Médicale Appliquée
- Kenneth Rainin Foundation
- European Commission
- Agence Nationale de la Recherche
- Institut National de la Santé et de la Recherche Médicale